Craig Capeci, MD
Sports Medicine · New York, NYNPI 1144426321
Payments from drug & device makers
Across 18 payments — averaging $207.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Stryker$716
- Joint Restoration Foundation, Inc.$289
- Boston Scientific$163
- Johnson & Johnson$38
- Sanofi-aventis U.S. LLC$22
- plus $11 from 1 others
What the payments were for
- Travel & lodging$2,30462%
- Food & beverage$1,43738%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 6 | $2,502 |
| Stryker | 6 | $716 |
| Joint Restoration Foundation, Inc. | 1 | $289 |
| Boston Scientific | 1 | $163 |
| Johnson & Johnson | 2 | $38 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$1,403
- JOURNEY$1,403
- RI.HIP NAVIGATION$1,403
- REAL INTELLIGENCE$1,403
- POLARSTEM$717
- MAKO$407
- T-Fix$170
- Journey II BCS$170
- PICO 7 Single Use Negative Pressure Wound Therapy$170
- REDAPT Revision Hip System$170
- WaveWriter Alpha Prime 16$163
- AETOS Shoulder System$142
- ACCOLADE$136
- INSIGNIA$134
How this compares
$3,741 in reported general payments places this provider in the 60th percentile of 403 sports medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 125 | $505 |
| Famotidine | 48 | $222 |
| Ondansetron Hcl | 48 | $218 |
| Oxycodone Hcl | 38 | $177 |
| Diclofenac Sodium | 16 | $146 |
| Tramadol Hcl | 32 | $127 |
| Cephalexin | 43 | $123 |
| Amoxicillin | 28 | $47 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in New York
- Riley WilliamsNew York$3.1M
- Gregory DifeliceNew York$3.1M
- Theodore BlaineNew York$845K
- Robert MeislinNew York$720K
- Danyal NawabiNew York$609K
- Bryan KellyNew York$409K
- Neil RothNew York$403K
- Michael AlaiaNew York$341K
- Eric StraussNew York$327K
- Samuel TaylorNew York$255K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.